GlaxoSmithKline Pharmaceuticals Limited — Others, 11-04-2025: Action(s) initiated or orders passed

GlaxoSmithKline Pharmaceuticals Limited has received an order from the CGST and Central Excise Authorities in Mumbai, demanding ₹21.63 crore. This includes ₹10.81 crore in tax and an equal amount in penalties and interest. The company identifies the claim as concerning the applicability of service tax on certain transactions. Importantly, GSK indicates that this order will not affect its financial operations, as it is currently assessing the situation and plans to respond appropriately. Investors may view this as a neutral impact on operations, although there could be potential implications depending on the outcome of the assessment.